FTXH Among Health Care ETFs
End-of-day Nov 18, 2026 · 31 Health care ETFs by 3Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.8% | −3.4% | +0.8% | +3.3% | +31.3% | +37.6% | +85.8% | +70.6% | +169.8% | +138.3% |
| Peer average | −0.9% | −5.3% | −1.4% | −2.4% | +17.0% | +21.8% | +68.8% | +23.4% | +169.9% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$83 of every $1,000 in FTXH is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly and Company | Healthcare | 8.35% | $834.87 | 64K | $91.2M |
| 2 | ABBVAbbVie | Healthcare | 7.79% | $779.05 | 291K | $85.1M |
| 3 | JNJJohnson & Johnson | Healthcare | 7.15% | $715.17 | 280K | $78.2M |
| 4 | PFEPfizer | Healthcare | 6.82% | $682.45 | 2.6M | $74.6M |
| 5 | MRKMerck | Healthcare | 6.62% | $661.94 | 505K | $72.3M |
| 6 | VTRSViatris | Healthcare | 4.22% | $422.50 | 2.3M | $46.2M |
| 7 | REGNRegeneron Pharmaceuticals | Healthcare | 4.09% | $408.81 | 47K | $44.7M |
| 8 | GILDGilead Sciences | Healthcare | 3.97% | $396.87 | 255K | $43.4M |
| 9 | BIIBBiogen | Healthcare | 3.95% | $394.86 | 172K | $43.2M |
| 10 | ZTSZoetis | Healthcare | 3.69% | $369.33 | 484K | $40.4M |
| 11 | AMGNAmgen | Healthcare | 3.63% | $363.38 | 87K | $39.7M |
| 12 | UTHRUnited Therapeutics | Healthcare | 3.47% | $346.54 | 65K | $37.9M |
| 13 | VRTXVertex Pharmaceuticals Incorporated | Healthcare | 3.35% | $334.64 | 68K | $36.6M |
| 14 | INCYIncyte | Healthcare | 3.26% | $325.99 | 299K | $35.6M |
| 15 | BMYBristol-Myers Squibb Company | Healthcare | 3.13% | $313.23 | 558K | $34.2M |
of the $111B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 8.35% |
| 2 | ABBV | AbbVie | 7.79% |
| 3 | JNJ | Johnson & Johnson | 7.15% |
| 4 | PFE | Pfizer | 6.82% |
| 5 | MRK | Merck & | 6.62% |
| 6 | VTRS | Viatris | 4.22% |
| 7 | REGN | Regeneron Pharmaceuticals | 4.09% |
| 8 | GILD | Gilead Sciences | 3.97% |
| 9 | BIIB | Biogen | 3.95% |
| 10 | ZTS | Zoetis | 3.69% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 24, 2026 | Sep 30, 2026 | $0.0113 |
| Jun 25, 2026 | Jun 30, 2026 | $0.0920 |
| Mar 26, 2026 | Mar 31, 2026 | $0.0573 |
| Dec 12, 2025 | Dec 31, 2025 | $0.13 |
| Sep 25, 2025 | Sep 30, 2025 | $0.15 |
| Jun 26, 2025 | Jun 30, 2025 | $0.0892 |
| Mar 27, 2025 | Mar 31, 2025 | $0.0992 |
| Dec 13, 2024 | Dec 31, 2024 | $0.13 |
| Sep 26, 2024 | Sep 30, 2024 | $0.12 |
| Jun 27, 2024 | Jun 28, 2024 | $0.13 |
| Mar 21, 2024 | Mar 28, 2024 | $0.0676 |
| Dec 22, 2023 | Dec 29, 2023 | $0.12 |